Jupiter Neurosciences Files S-1/A Amendment

TL;DR

JUPITER NEUROSCIENCES (JUPITER) filed an S-1/A amendment, signaling potential stock offering.

AI Summary

Jupiter Neurosciences, Inc. filed a Pre-Effective Amendment No. 19 to its Form S-1 Registration Statement on September 3, 2024. This filing relates to the registration of securities under the Securities Act of 1933. The company, formerly known as Jupiter Orphan Therapeutics, Inc., is incorporated in Delaware and is based in Jupiter, Florida.

Why It Matters

This S-1/A filing indicates Jupiter Neurosciences is moving forward with a securities registration, potentially leading to a public offering or other capital-raising activities.

Risk Assessment

Risk Level: medium — S-1/A filings are often precursors to public offerings, which carry inherent market and execution risks.

Key Numbers

• 333-260183 — SEC File Number (Identifies this specific registration filing)
• 19 — Amendment Number (Indicates this is the 19th amendment to the S-1 registration)

Key Players & Entities

• JUPITER NEUROSCIENCES, INC. (company) — Registrant
• 333-260183 (dollar_amount) — SEC File Number
• September 3, 2024 (date) — Filing Date
• Jupiter Orphan Therapeutics, Inc. (company) — Former Company Name
• Christer Rosén (person) — Chief Executive Officer

FAQ

From the Filing

0001493152-24-034903.txt : 20240904 0001493152-24-034903.hdr.sgml : 20240904 20240903215537 ACCESSION NUMBER: 0001493152-24-034903 CONFORMED SUBMISSION TYPE: S-1/A PUBLIC DOCUMENT COUNT: 32 FILED AS OF DATE: 20240904 DATE AS OF CHANGE: 20240903 FILER: COMPANY DATA: COMPANY CONFORMED NAME: JUPITER NEUROSCIENCES, INC. CENTRAL INDEX KEY: 0001679628 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 474828381 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: S-1/A SEC ACT: 1933 Act SEC FILE NUMBER: 333-260183 FILM NUMBER: 241275761 BUSINESS ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 BUSINESS PHONE: (561) 406-6154 MAIL ADDRESS: STREET 1: 1001 NORTH US HWY 1 STREET 2: SUITE 504 CITY: JUPITER STATE: FL ZIP: 33477 FORMER COMPANY: FORMER CONFORMED NAME: Jupiter Orphan Therapeutics, Inc. DATE OF NAME CHANGE: 20160713 S-1/A 1 forms-1a.htm As filed with the U.S. Securities and Exchange Commission on September 3, 2024 Registration No. 333-260183 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 PRE-EFFECTIVE AMENDMENT NO. 19 TO Form S-1 REGISTRATION STATEMENT UNDER THE SECURITIES ACT OF 1933 JUPITER NEUROSCIENCES, INC. (Exact name of registrant as specified in its charter) Delaware 2834 47-4828381 (State or other jurisdiction of incorporation or organization) (Primary Standard Industrial Classification Code Number) (I.R.S. Employer Identification Number) Jupiter Neurosciences, Inc. 1001 North US HWY 1, Suite 504 Jupiter, Florida 33477 Telephone: (561) 406-6154 (Address, including zip code, and telephone number, including area code, of registrant’s principal executive offices) Christer Rosén Chief Executive Officer Jupiter Neurosciences, Inc. 1001 North US HWY 1, Suite 504 Jupiter, Florida 33477 Telephone: (561) 406-6154 (Name, address, including zip code, and telephone number, including area code, of agent for service) Copies to: Laura Anthony, Esq. Craig D. Linder, Esq. Anthony, Linder & Cacomanolis, PLLC 1700 Palm Beach Lakes Blvd., Suite 820 West Palm Beach, Florida 33401 Telephone: (561) 514-0936 Facsimile: (561) 514-0832 Ralph De Martino, Esq. Cavas Pavri, Esq. ArentFox Schiff LLP 1717 K Street NW Washington, DC 20006 Telephone: (202) 857-6000 Facsimile: (202) 857-6395 Approximate date of commencement of proposed sale to the public: As soon as practicable after the effective date of this registration statement. If any of the securities being registered on this Form are to be offered on a delayed or continuous basis pursuant to Rule 415 under the Securities Act of 1933 check the following box. ☐ If this Form is filed to register additional securities for an offering pursuant to Rule 462(b) under the Securities Act, please check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(c) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ If this Form is a post-effective amendment filed pursuant to Rule 462(d) under the Securities Act, check the following box and list the Securities Act registration statement number of the earlier effective registration statement for the same offering. ☐ Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act. Large accelerated filer ☐ Accelerated filer ☐ Non-accelerated file